Welcome to our dedicated page for CNO Financial Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNO Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNO Financial Group's regulatory disclosures and financial reporting.
CNO Financial Group Chief Marketing Officer Rocco F. Tarasi III sold 1,891 shares of common stock in an open-market transaction at a price of $51.31 per share. After this sale, he directly holds 77,300 shares of CNO common stock.
The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 24, 2026, indicating it was scheduled in advance rather than timed discretionarily.
CNO Financial Group (CNO) filing a Section 144 notice for proposed sales of Common Stock by a broker-dealer account. The filing lists a reported value of $4,429,456.76 and a reference figure of 93,348,503 dated 06/30/2026. The schedule shows 44,250 shares tied to a Stock Option Exercise on 06/30/2026 and 41,798 shares identified as Restricted Stock with a 03/25/2026 date.
CNO notice of proposed sale of 5,750 shares of Common Stock by means of a stock option exercise to be effected on 06/11/2026. The filing lists the sale method as cash and identifies the transaction party as ISSUER.
The excerpt also records recent sales by Rocco Tarasi: 3,308 shares sold on 06/10/2026 for $162,092 and 4,808 shares sold on 06/02/2026 for $225,976.
CNO Financial Group Chief Marketing Officer Rocco F. Tarasi III exercised stock options and sold shares in CNO Financial Group, Inc. common stock. He exercised 5,750 options at $21.06 per share and on the same date sold 5,750 shares at $50.00 per share in an open-market sale. He also sold 3,308 shares at $49.00 per share on a prior trading day. These sales were made under a Rule 10b5-1 trading plan adopted on February 24, 2026. After the transactions, he directly owns 79,191 common shares, showing he continues to hold a substantial equity stake.
CNO filed a Rule 144 notice disclosing planned sales of common stock originally issued as performance shares. The filing lists Morgan Stanley Smith Barney LLC in the issuer block and shows a reported transaction by Rocco Tarasi on 06/02/2026 for 4,808 shares with an associated numeric entry of 225,976.00.
CNO Financial Group, Inc. executive Scott L. Goldberg, President of the Consumer Division, reported an administrative share disposition. On June 4, 2026, 396 shares of common stock were surrendered to the company to cover required tax withholding on vested restricted stock units. Following this tax-withholding event, he directly holds 206,092 common shares. This was not an open-market trade but a routine compensation-related transaction.
CNO Financial Group Chief Marketing Officer Rocco F. Tarasi III reported an open-market sale of 4,808 shares of Common Stock at $47.00 per share. The transaction took place on June 2, 2026 and was executed under a Rule 10b5-1 trading plan adopted on February 24, 2026.
Following this sale, Tarasi directly holds 82,499 shares of CNO Financial Group common stock. Because the sale was made pursuant to a pre-arranged 10b5-1 plan, its timing reflects a scheduled trading program rather than a discretionary one-time decision.
CNO Financial Group, Inc. reported the results of its 2026 Annual Meeting of Shareholders held on May 12, 2026. Shareholders elected nine directors to one-year terms ending at the 2027 annual meeting, with each nominee receiving over 80 million votes in favor and only modest opposition.
Shareholders also approved, on a non-binding advisory basis, the executive compensation of the company’s named executive officers, with 79,637,913 votes for, 1,675,840 against, and 168,450 abstentions. In addition, they ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026, with 83,949,859 votes for, 1,766,276 against, and 58,887 abstentions.